Drug developers are getting closer to tapping an unmined gold reserve of protein–protein interaction targets.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Disrupting the α-synuclein-ESCRT interaction with a peptide inhibitor mitigates neurodegeneration in preclinical models of Parkinson’s disease
Nature Communications Open Access 19 April 2023
-
Characterisation of a cyclic peptide that binds to the RAS binding domain of phosphoinositide 3-kinase p110α
Scientific Reports Open Access 02 February 2023
-
Identification of novel inhibitors of Keap1/Nrf2 by a promising method combining protein–protein interaction-oriented library and machine learning
Scientific Reports Open Access 01 April 2021
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Rights and permissions
About this article
Cite this article
Mullard, A. Protein–protein interaction inhibitors get into the groove. Nat Rev Drug Discov 11, 173–175 (2012). https://doi.org/10.1038/nrd3680
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrd3680
This article is cited by
-
Characterisation of a cyclic peptide that binds to the RAS binding domain of phosphoinositide 3-kinase p110α
Scientific Reports (2023)
-
Disrupting the α-synuclein-ESCRT interaction with a peptide inhibitor mitigates neurodegeneration in preclinical models of Parkinson’s disease
Nature Communications (2023)
-
Identification of novel inhibitors of Keap1/Nrf2 by a promising method combining protein–protein interaction-oriented library and machine learning
Scientific Reports (2021)
-
The CASP13-CAPRI targets as case studies to illustrate a novel scoring pipeline integrating CONSRANK with clustering and interface analyses
BMC Bioinformatics (2020)
-
Photoregulated macrocyclic cell-penetrating peptides (microreview)
Chemistry of Heterocyclic Compounds (2020)